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Abstract
Background:  Initial low maternal serum β-human chorionic go-
nadotropin (β-hCG) is a good predictor of early pregnancy demise. 
Our objective was to determine its predictive value in determining 
the long-term outcome in ICSI pregnancies.
Methods:  A retrospective cohort study was designed at the Sau-
di Center for Assisted Reproduction. Two hundred and sixty-one 
women with ICSI pregnancies were followed up from initial β-hCG 
level determination till the end of pregnancy. Accuracy of early 
β-hCG in predicting the occurrence of a live-birth, ongoing preg-
nancy, late miscarriage, ectopic pregnancy and early miscarriage 
following ICSI was measured.
Results:  β-hCG levels were significantly different in pregnancies 
that reached the stage of an ongoing pregnancy and live-birth as 
compared to early pregnancy loss. The ROC curves demonstrated 
a high sensitivity for identifying patients with ectopic pregnancies 
and early miscarriage (100% and 93.33% respectively). The re-
maining results ranged from a sensitivity of 69% to 79% and speci-
ficity of 62% to 75%.
Conclusions:  In ICSI pregnancies, a single early β-hCG may help 
to identify pregnancies that will reach full-term and delivery.
Keywords:  ICSI; Human chorionic gonadotropin; Outcome; 
Pregnancy
Introduction
Human chorionic gonadotropin (hCG), being produced and 
secreted by syncytial trophoblast, is a vital part of early preg-
nancy. Through the stimulation of luteinizing hormone (LH) 
receptors, it maintains the corpus luteum and progesterone 
production. Additionally, since it is produced by the early fe-
tus, and can be measured in maternal serum, it is commonly 
used for determination and viability of early pregnancy [1]. 
The hCG structure is divided into two main subsets (α and 
β) with the former identical to that of LH, follicle stimulat-
ing hormone (FSH) and thyroid stimulating hormone (TSH) 
subsets, while the latter is specific to hCG.
HCG levels significantly increase during early pregnan-
cy with levels doubling approximately every 48 hours [2]. 
This yardstick has become of importance in identifying cases 
of possible poor pregnancy outcome (for exemple, early mis-
carriage, ectopic pregnancy) [3-13]. However, the accuracy 
of using hCG to determine long-term pregnancy outcomes 
has been little investigated in women with a history of in-
fertility and pregnancy following ovarian stimulation and 
exogenous luteal phase support. Therefore we wished to de-
termine if early β-hCG determination can accurately forecast 
the outcome of ICSI pregnancies.
 
Materials and Methods
Patient population
This retrospective study was approved by our institutional 
review board. We performed a computerized search of our 
unit’s patient record database for women who underwent 
ICSI at our center, had a positive initial β-hCG on day 14 
post embryo transfer pregnancy test, and were followed up 
until the end of the pregnancy. Two hundred and sixty-one 
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women met our inclusion criteria and were identified for 
analysis.
ICSI protocol
Our center’s ovarian stimulation and embryo transfer pro-
tocols  have  been  published  previously  [14,  15].  In  brief, 
women were down-regulated using a gonadotropin-releasing 
hormone agonist (Decapeptyl, Ferring NV, Belgium) proto-
col, followed by ovarian stimulation using recombinant FSH 
(rFSH, Puregon, NV Organon, Oss, The Netherlands) and/
or  human  menopausal  gonadotrophin  (Menogon,  Ferring 
NV, Belgium) till the day of hCG administration. When the 
leading follicle reached about 18 mm in diameter, 10,000 IU 
of hCG (Pergnyl, NV Organon, The Netherlands) was given 
intramuscularly, and oocyte retrieval was performed 34 - 36 
hours later. Embryo transfer was performed on day 3 using a 
standardized technique using a soft Edward-Wallace or Cook 
catheter with the embryos deposited about 1 cm from the 
uterine fundus. Luteal phase support is provided in the form 
of daily progesterone vaginal suppositories every 12 hours 
(Cycologest 400 mg; Hoechst Roussel Limited, UK).
It is important to note that even the vast majority of pa-
tients in each group were less than 35 years old, an average 
of about 3 embryos were transferred since, as a referral cen-
ter, most of our patients had previous failed trials in different 
centers.
Hormone assays   
Samples of venous blood were collected routinely two weeks 
post-ET.  Serum  β-hCG  concentrations  were  measured  by 
Mini Vidas, Biomereux, Italy. Patients who became pregnant 
following ICSI were followed up until the end of pregnancy 
at our center.
Outcome measures
The primary outcome measure for this study was to deter-
mine the accuracy of early β-hCG in predicting the occur-
rence of a live-birth. Additionally, we wished to determine 
the accuracy of early β-hCG in predicting the occurrence of 
an ongoing pregnancy, a late miscarriage, an ectopic preg-
nancy, or an early miscarriage following ICSI. Live-birth 
was defined as the live-birth of an infant at 20 or more com-
pleted weeks of gestation. Ongoing pregnancy was defined 
as an intrauterine live fetus 14 weeks or more of gestation. 
Miscarriage was defined as pregnancy termination prior to 
20 weeks gestation as confirmed by ultrasound, pregnancy 
test or by histology. Ectopic pregnancy was defined as an 
extra-uterine gestation as determined by ultrasound and con-
firmed by histopathology.
Statistical analysis
All analyses of significance were two-sided and tested at the 
5% level; values of P < 0.05 were considered to indicate sig-
nificant differences. Continuous variables were tested if they 
presented normal distribution using the f-test. Accordingly, 
the Student t or Mann-Whitney U tests for parametric and 
nonparametric data, respectively, were applied. A receiver 
operating characteristic (ROC) curve was used to determine 
the  β-hCG  cut-off  level  that  best  discriminated  between 
pregnancy outcomes. Clinical and demographic data are also 
presented as mean (± SD) or as frequency distribution for 
simplicity. Statistical analysis was performed using the com-
puter statistical package Stats Direct (Stats Direct, Ltd, UK). 
Results
The patient demographics and characteristics cycle did not 
differ between the groups with no significant difference with 
regards to patient age, period of infertility, and day-3 FSH 
levels (Table 1). Even so, the β-hCG levels were statistically 
significantly higher in pregnancies that reached the stage of 
an ongoing pregnancy and live-birth as compared to early 
pregnancy termination (Table 2). Additionally, pregnancies 
with an ectopic implantation or that had an early miscarriage 
showed significantly lower average β-hCG levels that preg-
nancies were viable for longer gestations. Pregnancies with 
late miscarriages had a lower average β-hCG level that preg-
nancies were viable for longer gestations, but this did not 
reach statistical significance.
The results of the ROC curves for each stage of preg-
nancy termination demonstrated revealed a high sensitivity 
for identifying patients with ectopic pregnancies and early 
miscarriage (100% and 93.33% respectively) (Table 3, Fig. 
1). The remaining results ranged from a sensitivity of 69% to 
79% and specificity of 62% to 75%.
Discussion
  
The early weeks of fetal development are highly sensitive to 
changes in the embryonic milieu. Pregnancy survival past 
the initial critical weeks of embryonic development depends 
upon proper functioning of both the maternal and fetal endo-
crinological systems. Any imbalance may result in failure of 
the pregnancy to become viable and reach the stage of full 
embryonic development. Since β-hCG levels represent tro-
phoblastic mass and function in the early fetal stages, its ma-
ternal serum concentration grows in a linear pattern to fetal 
growth and development with any divergence from this pre-
defined incremental curve a suspicious sign of fetal develop-
mental abnormality [16-18]. Low initial β-hCG values have 
additionally been linked to a poor prognosis [3-13]. Even so, 
what remains unclear is whether this highly accurate test for 
determination of early pregnancy demise is as accurate for 
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long-term pregnancy outcomes. 
As compared with the general population, early preg-
nancy monitoring is more highly emphasized in patients who 
become pregnant following assisted reproductive technolo-
gies (ART). Early pregnancy complications including ecto-
pic pregnancies, abnormal fetal development, and chromo-
somal aberrations are higher in ART babies than naturally 
conceived children [19]. Additionally, couple’s anxiety and 
the costs associated with ART make all children born using 
assisted reproduction ‘precious babies’. These factors make 
the qualitative evaluation of ART pregnancies more impor-
tant than their naturally conceived counterparts.
Measuring  quantitative  serum  β-hCG  has  been  used 
for predicting pregnancy outcome since the 1960s. Zegers-
Hochschield et al [13] compared early hCG levels in patients 
who conceived naturally or through assisted reproduction 
and noted that the former had significantly higher hCG lev-
els. Additionally, Confino et al [4] noted that the patients 
with poor outcomes (for example, miscarriage) had statisti-
cally lower hCG levels than normal pregnancies. Indirectly 
this may relate to a higher incidence of poor outcomes in 
ICSI pregnancies compared with naturally conceived preg-
nancies. 
The predictive value of a single early β-hCG measure-
ment on early pregnancy outcome has been studied by previ-
ous investigators [3-13]. Fridstrom et al [20] demonstrated 
that a day 14 post-ET β-hCG level of more than 150 IU/L 
had a 79% sensitivity and 78% specificity in distinguish-
ing between viable and pathological pregnancies. Similarly, 
Bjercke et al [21] noted that pregnancies with a β-hCG level 
of more than 55 IU/L on day 12 had a 90% probability of 
reaching the stage of an ongoing pregnancy. 
The results of this study demonstrate further support for 
the findings by previous investigators, and additionally, pro-
vide evidence of a correlation between early β-hCG levels 
and the probability of a positive pregnancy outcome. This 
may suggest that fetuses with higher initial production of 
β-hCG are more biologically competent and therefore more 
likely to reach the stage of delivery
In conclusion, in the current study we found that, in ICSI 
  Live-birth
Ongoing 
Pregnancy
Late 
Miscarriage
Ectopic 
Pregnancy
Early Miscarriage
Age 29.54 ± 5.05 29.61 ± 4.91 29.69 ± 5.29 30.4 ± 1.67 30.8 ± 4.83
Infertility duration 7.9 ± 3.97 8.34 ± 4.21 7.85 ± 4.43 10.4 ± 3.13 8.2 ± 5.23
No. of ampoules 51.59 ± 256.71 46.4 ± 230.91 27.87 ± 7.62 23 ± 7.42 29.71 ± 12.27
Days of stimulation 9.78 ± 1.86 9.78 ± 1.8 10.15 ± 2.92 9.2 ± 1.92 9.87 ± 1.73
No. of oocytes 
retrieved
12.48 ± 7.52 12.13 ± 7.33 13.25 ± 9.89 12 ± 6.44 11.8 ± 7.32
No. of MII 10.04 ± 6.47 9.76 ± 6.28 10.79 ± 8 10.6 ± 6.23 10.33 ± 6.77
Injected 10.12 ± 6.41 9.85 ± 6.22 10.71 ± 7.22 10.6 ± 6.23 10.33 ± 6.77
Fertilized 7.04 ± 4.51 6.78 ± 4.45 7.03 ± 5.48 5.4 ± 4.72 7.73 ± 5.57
Good embryo G1 4.15 ± 3.4 4.01 ± 3.23 3.94 ± 3.75 3.6 ± 2.88 5.2 ± 5.73
Fair embryo G2  2.43 ± 2.19 2.37 ± 2.07 2.49 ± 2.45 2.4 ± 2.61 2.33 ± 1.68
Poor embryo G3, 
G4
1.22 ± 1.76 1.14 ± 1.66 1.29 ± 1.67 0 ± 0 0.6 ± 1.35
No. of ET 3.75 ± 0.81 3.74 ± 0.83 3.76 ± 0.83 3.2 ± 1.3 3.4 ± 1.06
Table 1. Patient Demographics and Cycle Characteristics Between Pregnancies That Reached Different Stages of 
Pregnancy
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pregnancies, a single early β-hCG may help to identify preg-
nancies that will reach full-term and delivery. These results 
may help to reassure patients and help to identify high-risk 
pregnancies early on.
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